Susquehanna International Group, LLP Novan, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.95 - $4.41 $134,520 - $201,096	-45,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $273,637 - $553,385	-67,900 Reduced 59.82%	45,600 $190,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $10.17 $848,980 - $1.15 Million	113,500 New	113,500 $924,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.